ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
More positive results for Pfizer/Lilly’s non-opioid pain drug
February 22, 2019Pfizer and Eli Lilly have announced more positive results from a phase 3 study of their non-opioid pain drug tanezumab, this time in chronic lower back pain (CBLP). -
Lexicon pain drug advances after clearing early clinical test
December 25, 2018A phase 1a trial of Lexicon Pharmaceuticals’ LX9211 has met its primary objectives. The study found the AAK1 inhibitor was well tolerated, teeing Lexicon up to advance the neuropathic pain prospect..... -
Pfizer again supplying pain drugs to veterinarians shunted aside because of hospital shortages
December 19, 2018Pfizer shut off supplies of pain drugs to veterinarians when a shortage of an injected opioid meant it couldn’t fill all of the orders it had from hospitals. But relief is now on the way for vets and their animal patients, the FDA says. -
US delay for AbbVie/Neurocrine’s uterine pain drug
April 13, 2018The US Food and Drug Administration has extended its review of AbbVie and Neurocrine’s experimental uterine pain drug elagolix by three months. -
Piramal buys Mallinckrodt’s pain drug portfolio
March 21, 2017Piramal’s critical care business is a global player in the hospital generics segment
Pharma Sources Insight January 2025
